Alector (ALEC) Short-term Investments (2018 - 2026)
Alector's (ALEC) quarterly Short-term Investments came in at $112.9 million in Q2 2026, down 57.0% year-over-year from $262.5 million in Q2 2025, and down 12.87% quarter-over-quarter from $129.6 million in Q1 2026.
Analysis
Alector (ALEC) Short-term Investments (2018 - 2026) Analysis & Trends
Alector (ALEC) has reported Short-term Investments for 9 consecutive years, with $112.9 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Short-term Investments fell 57.0% year-over-year to $112.9 million in Q2 2026; TTM through Jun 2026 was $112.9 million, a 57.0% decrease from a year earlier, with the FY2025 full-year figure at $190.2 million, down 49.99% from the prior year.
- Short-term Investments was $112.9 million for Q2 2026 at Alector, down from $129.6 million in the prior quarter.
- Over five years, Short-term Investments peaked at $636.6 million in Q2 2022 and troughed at $112.9 million in Q2 2026.
- A 5-year average of $393.8 million and a median of $437.9 million in 2024 frame the typical range for Short-term Investments.
- Across the five-year window, Short-term Investments soared 228.38% in 2022 and tumbled 59.08% in 2026, its largest moves.
- Over 5 years, Short-term Investments stood at $558.5 million in 2022, then slipped by 15.08% to $474.3 million in 2023, then declined by 19.8% to $380.4 million in 2024, then slumped by 49.99% to $190.2 million in 2025, then slumped by 40.66% to $112.9 million in 2026.
- The last three Short-term Investments figures came in at $112.9 million (Q2 2026), $129.6 million (Q1 2026), and $190.2 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | Alector | 274.68 Mn | 101.88 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 112.88 Mn |
| Mar 31, 2026 | 129.55 Mn |
| Dec 31, 2025 | 190.22 Mn |
| Sep 30, 2025 | 214.61 Mn |
| Jun 30, 2025 | 262.51 Mn |
| Mar 31, 2025 | 316.58 Mn |
| Dec 31, 2024 | 380.38 Mn |
| Sep 30, 2024 | 420.04 Mn |
| Jun 30, 2024 | 455.79 Mn |
| Mar 31, 2024 | 489.53 Mn |
| Dec 31, 2023 | 474.31 Mn |
| Sep 30, 2023 | 486.90 Mn |
| Jun 30, 2023 | 498.51 Mn |
| Mar 31, 2023 | 473.77 Mn |
| Dec 31, 2022 | 558.53 Mn |
| Sep 30, 2022 | 574.08 Mn |
| Jun 30, 2022 | 636.59 Mn |
| Mar 31, 2022 | 413.95 Mn |
| Dec 31, 2021 | 406.10 Mn |
| Sep 30, 2021 | 261.32 Mn |